Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Title PubMed Authors Journal Year Studies
The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death. 21782037 Marcus PM, Gareen IF, Miller AB, Rosenbaum J, Keating K, Aberle DR, Berg CD Contemp Clin Trials 2011 NLST
In vivo detection of acinar microstructural changes in early emphysema with (3)He lung morphometry. 21734160 Quirk JD, Lutey BA, Gierada DS, Woods JC, Senior RM, Lefrak SS, Sukstanskii AL, Conradi MS, Yablonskiy DA Radiology 2011 NLST
Quantitative CT assessment of emphysema and airways in relation to lung cancer risk. 21900623 Gierada DS, Guniganti P, Newman BJ, Dransfield MT, Kvale PA, Lynch DA, Pilgram TK Radiology 2011 NLST
Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST). 22045816 Kramer BS, Berg CD, Aberle DR, Prorok PC J Med Screen 2011 NLST
Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial. 22021510 Larke FJ, Kruger RL, Cagnon CH, Flynn MJ, McNitt-Gray MM, Wu X, Judy PF, Cody DD AJR Am J Roentgenol 2011 NLST
The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. 21057003 Atkinson JJ, Lutey BA, Suzuki Y, Toennies HM, Kelley DG, Kobayashi DK, Ijem WG, Deslee G, Moore CH, Jacobs ME, Conradi SH, Gierada DS, Pierce RA, Betsuyaku T, Senior RM Am. J. Respir. Crit. Care Med. 2011 NLST
A special program to increase the participation of Hispanics in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Tenorio SL, Gamito EJ, Ogden S, Quintela J, Ordonez E, Crawford ED, Lamerato L Hisp Health Care Int 2011 PLCO
Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. Singh S, Pinsky P, Fineberg N, Gierada DS, Garg K, Sun Y, Nath PH Radiology 2011 NLST
Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study. 21715603 Chaturvedi AK, Kemp TJ, Pfeiffer RM, Biancotto A, Williams M, Munuo S, Purdue MP, Hsing AW, Pinto L, McCoy JP, Hildesheim A Cancer Epidemiol. Biomarkers Prev. 2011 PLCO
Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial. 21242173 Duda C, Mahon I, Chen MH, Snyder B, Barr R, Chiles C, Falk R, Fishman EK, Gemmel D, Goldin JG, Brown K, Munden RF, Vydareny K, Aberle DR Clin Trials 2011 NLST
Evaluation of polygenic risk scores for predicting breast and prostate cancer risk. 21618606 Machiela MJ, Chen CY, Chen C, Chanock SJ, Hunter DJ, Kraft P Genet. Epidemiol. 2011 PLCO
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. 21465221 Kote-Jarai Z, Amin Al Olama A, Leongamornlert D, Tymrakiewicz M, Saunders E, Guy M, Giles GG, Severi G, Southey M, Hopper JL, Sit KC, Harris JM, Batra J, Spurdle AB, Clements JA, Hamdy F, Neal D, Donovan J, Muir K, Pharoah PD, Chanock SJ, Brown N, B… Hum. Genet. 2011 PLCO
Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. 21372204 Ciampa J, Yeager M, Amundadottir L, Jacobs K, Kraft P, Chung C, Wacholder S, Yu K, Wheeler W, Thun MJ, Divers WR, Gapstur S, Albanes D, Virtamo J, Weinstein S, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Hunter D, Hoover R, Tho… Cancer Res. 2011 PLCO
Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. 21637779 Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Chanock SJ, Kolb S, Signorello LB, Yamamura Y, Neslund-Dudas C, Thun MJ, Murphy A, Casey G, Sheng X, Wan P, Pooler LC, M… PLoS Genet. 2011 PLCO
Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. 21343373 Ahn J, Kibel AS, Park JY, Rebbeck TR, Rennert H, Stanford JL, Ostrander EA, Chanock S, Wang MH, Mittal RD, Isaacs WB, Platz EA, Hayes RB Clin. Cancer Res. 2011 PLCO
Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions. 22086326 Ciampa J, Yeager M, Jacobs K, Thun MJ, Gapstur S, Albanes D, Virtamo J, Weinstein SJ, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Hunter D, Hoover R, Thomas G, Chanock S, Holmes C, Chatterjee N Hum. Hered. 2011 PLCO
Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. 21531787 Chung CC, Ciampa J, Yeager M, Jacobs KB, Berndt SI, Hayes RB, Gonzalez-Bosquet J, Kraft P, Wacholder S, Orr N, Yu K, Hutchinson A, Boland J, Chen Q, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Cancel-Tassin G, … Hum. Mol. Genet. 2011 PLCO
Genome-wide association study of relative telomere length. 21573004 Prescott J, Kraft P, Chasman DI, Savage SA, Mirabello L, Berndt SI, Weissfeld JL, Han J, Hayes RB, Chanock SJ, Hunter DJ, De Vivo I PLoS ONE 2011 PLCO
A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. 21824976 Garcia-Closas M, Ye Y, Rothman N, Figueroa JD, Malats N, Dinney CP, Chatterjee N, Prokunina-Olsson L, Wang Z, Lin J, Real FX, Jacobs KB, Baris D, Thun M, De Vivo I, Albanes D, Purdue MP, Kogevinas M, Kamat AM, Lerner SP, Grossman HB, Gu J, Pu X, Hut… Hum. Mol. Genet. 2011 PLCO
Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. 22033276 Stevens KN, Garcia-Closas M, Fredericksen Z, Kosel M, Pankratz VS, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Van 't Veer LJ, Tollenaar RA, Fasching PA, Beckmann MW, Hein A, Ekici AB, Johnson N, Peto J, dos Santos Silva I, Gib… Br. J. Cancer 2011 PLCO